Revenue Recognition - Deferred Revenues (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenue recognized during the period that was included in deferred revenues at the beginning of the period	$ 13,693	$ 10,564
Revenue recognized	20,900
Deferred revenue, current portion	19,754	16,612
Deferred revenue, Long-term	16,838	19,128
Deferred revenue	36,592	$ 35,740	$ 30,778
BGI Genomics
Revenue recognized	44,000		$ 0
Deferred revenue, current portion	500
Deferred revenue, Long-term	16,800
Deferred revenue	17,300
Foundation Medicine ("FMI")
Revenue recognized	24,300
Deferred revenue, current portion	1,700
Deferred revenue	1,700
BGI Genomics and Foundation Medicine
Revenue recognized during the period that was included in deferred revenues at the beginning of the period	2,900
Deferred revenue	17,600
Genetic testing services
Revenue recognized during the period that was included in deferred revenues at the beginning of the period	$ 10,800